4-N-(2,2-difluoro-2-pyridin-2-ylethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine;7-(1H-pyrazol-5-yl)-4-(1H-pyrazol-5-ylmethoxy)quinolin-2-amine;7-(1H-pyrazol-5-yl)-4-N-[[(2R)-pyrrolidin-2-yl]methyl]quinoline-2,4-diamine;4-N-(pyridin-2-ylmethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine;4-N-(pyridin-3-ylmethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine
C91H85F2N27O — CID 158860377
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-N-(2,2-difluoro-2-pyridin-2-ylethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine;7-(1H-pyrazol-5-yl)-4-(1H-pyrazol-5-ylmethoxy)quinolin-2-amine;7-(1H-pyrazol-5-yl)-4-N-[[(2R)-pyrrolidin-2-yl]methyl]quinoline-2,4-diamine;4-N-(pyridin-2-ylmethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine;4-N-(pyridin-3-ylmethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine
4-N-(2,2-difluoro-2-pyridin-2-ylethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine;7-(1H-pyrazol-5-yl)-4-(1H-pyrazol-5-ylmethoxy)quinolin-2-amine;7-(1H-pyrazol-5-yl)-4-N-[[(2R)-pyrrolidin-2-yl]methyl]quinoline-2,4-diamine;4-N-(pyridin-2-ylmethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine;4-N-(pyridin-3-ylmethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine (PubChem CID 158860377) has the molecular formula C91H85F2N27O and a molecular weight of 1610.86 g/mol. Its IUPAC name is 4-N-(2,2-difluoro-2-pyridin-2-ylethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine;7-(1H-pyrazol-5-yl)-4-(1H-pyrazol-5-ylmethoxy)quinolin-2-amine;7-(1H-pyrazol-5-yl)-4-N-[[(2R)-pyrrolidin-2-yl]methyl]quinoline-2,4-diamine;4-N-(pyridin-2-ylmethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine;4-N-(pyridin-3-ylmethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine.
Molecular Properties
| Compound Name | 4-N-(2,2-difluoro-2-pyridin-2-ylethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine;7-(1H-pyrazol-5-yl)-4-(1H-pyrazol-5-ylmethoxy)quinolin-2-amine;7-(1H-pyrazol-5-yl)-4-N-[[(2R)-pyrrolidin-2-yl]methyl]quinoline-2,4-diamine;4-N-(pyridin-2-ylmethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine;4-N-(pyridin-3-ylmethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine |
|---|---|
| PubChem CID | 158860377 |
| Molecular Formula | C91H85F2N27O |
| Molecular Weight | 1610.86 g/mol |
| Exact Mass | 1609.74 |
| IUPAC Name | 4-N-(2,2-difluoro-2-pyridin-2-ylethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine;7-(1H-pyrazol-5-yl)-4-(1H-pyrazol-5-ylmethoxy)quinolin-2-amine;7-(1H-pyrazol-5-yl)-4-N-[[(2R)-pyrrolidin-2-yl]methyl]quinoline-2,4-diamine;4-N-(pyridin-2-ylmethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine;4-N-(pyridin-3-ylmethyl)-7-(2H-pyrrol-3-yl)quinoline-2,4-diamine |
| SMILES | Nc1cc(NCC(F)(F)c2ccccn2)c2ccc(C3=CC=NC3)cc2n1.Nc1cc(NC[C@H]2CCCN2)c2ccc(-c3ccn[nH]3)cc2n1.Nc1cc(NCc2ccccn2)c2ccc(C3=CC=NC3)cc2n1.Nc1cc(NCc2cccnc2)c2ccc(C3=CC=NC3)cc2n1.Nc1cc(OCc2ccn[nH]2)c2ccc(-c3ccn[nH]3)cc2n1 |
| InChI | InChI=1S/C20H17F2N5.2C19H17N5.C17H20N6.C16H14N6O/c21-20(22,18-3-1-2-7-25-18)12-26-16-10-19(23)27-17-9-13(4-5-15(16)17)14-6-8-24-11-14;20-19-9-17(23-11-13-2-1-6-21-10-13)16-4-3-14(8-18(16)24-19)15-5-7-22-12-15;20-19-10-17(23-12-15-3-1-2-7-22-15)16-5-4-13(9-18(16)24-19)14-6-8-21-11-14;18-17-9-15(20-10-12-2-1-6-19-12)13-4-3-11(8-16(13)22-17)14-5-7-21-23-14;17-16-8-15(23-9-11-3-5-18-21-11)12-2-1-10(7-14(12)20-16)13-4-6-19-22-13/h1-10H,11-12H2,(H3,23,26,27);2*1-10H,11-12H2,(H3,20,23,24);3-5,7-9,12,19H,1-2,6,10H2,(H,21,23)(H3,18,20,22);1-8H,9H2,(H2,17,20)(H,18,21)(H,19,22)/t;;;12-;/m...1./s1 |
| InChIKey | JAOQMAQRZDUDOB-AHHMKHIISA-N |
| XLogP | 15.35 |
| TPSA | 425.72 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 121 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1610.86 |
| LogP ≤ 5 | 15.35 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 25 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158860377 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.